Bollard Group’s Kindred Biosciences, Inc. KIN Stock Holding History

Bollard Group’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,129	Closed	-$29K	–	430
2021 Q2	$29K	Hold	3,129	–	–	﹤0.01%	381
2021 Q1	$16K	Hold	3,129	–	–	﹤0.01%	402
2020 Q4	$13K	Hold	3,129	–	–	﹤0.01%	403
2020 Q3	$13K	Sell	3,129 -9,876	-76%	-$41.3K	﹤0.01%	403
2020 Q2	$58K	Buy	+13,005	New	+$58.1K	﹤0.01%	327

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Bollard Group's KIN Position: Q3 2021 in Review

Bollard Group sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 3,129 shares — an estimated $29K sold.

Bollard Group first reported a position in KIN in Q2 2020 and held it in 5 quarters. The position peaked at $58K in Q2 2020. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Bollard Group reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Bollard Group sold 3,129 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $29K.
Bollard Group first reported a position in Kindred Biosciences, Inc. in Q2 2020 and held it in 5 quarters.
Bollard Group's Kindred Biosciences, Inc. position peaked at $58K in Q2 2020.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Bollard Group's 13F filing for Q3 2021, filed 12 Nov 2021.